semaglutide mdv Injectable | Compounded GLP-1 FullScopeMD | Semaglutide (Injectable)

Rapid blood pressure changes from diabetes treatment could impact the blood supply to the optic nerve

Those with a history of sensitivity to other injectable medications could also be at a slightly higher risk

David Ricks, Chair and Chief Executive Officer of Eli Lilly, noted that fewer than one in ten people who could benefit from a GLP-1 therapy are currently taking one, citing access barriers, stigma, and the complexity of existing treatment options

New Engl J Med (2017) 377:64457

Among the GLP1-RA agents, once-weekly semaglutide may be especially promising in type 1 diabetes, as this agent has demonstrated superiority over other GLP1-RAs in terms of glycaemic control and weight loss in type 2 diabetes, as well as good tolerability [56]

Journal of Clinical Psychopharmacology , 36(1), 18-26